List of works - Katarina Ejeskär

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

scientific article published on September 2004

Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas.

scientific article published on 18 April 2013

Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours

article

Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.

scientific article published in January 2000

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.

scientific article published on December 1999

High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival.

scientific article

Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death

scientific article

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene ⬇️

scientific article published on June 1, 1998

Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT.

scientific article

MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression

scientific article published on 08 June 2020

Method for efficient transfection of in vitro-transcribed mRNA into SK-N-AS and HEK293 cells: difference in the toxicity of nuclear EGFP compared to cytoplasmic EGFP.

scientific article published on June 2006

Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.

scientific article published on 01 January 2007

Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.

scientific article

Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma

scientific article published on 12 December 2012

The Unique Non-Catalytic C-Terminus of P37delta-PI3K Adds Proliferative Properties In Vitro and In Vivo

scientific article published on 29 May 2015

The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma

scientific article published on 16 March 2021

Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development

scientific article published on 01 June 1999

Verification of microRNA expression in human endometrial adenocarcinoma.

scientific article

model of myosin myopathy rescued by overexpression of a TRIM-protein family member

scientific article published on 26 June 2018

p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors ⬇️

scientific article published on October 24, 2011

List of works by Katarina Ejeskär

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas.

Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours

Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.

High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival.

Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene ⬇️

Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT.

MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression

Method for efficient transfection of in vitro-transcribed mRNA into SK-N-AS and HEK293 cells: difference in the toxicity of nuclear EGFP compared to cytoplasmic EGFP.

Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.

Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.

Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma

The Unique Non-Catalytic C-Terminus of P37delta-PI3K Adds Proliferative Properties In Vitro and In Vivo

The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma

Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development

Verification of microRNA expression in human endometrial adenocarcinoma.

model of myosin myopathy rescued by overexpression of a TRIM-protein family member

p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors ⬇️